Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Weekly Recap: IPO market turns friendly as seven companies go public
Analyst IPO Market Commentary
As we noted in a
mid-week blog post
, AAAP had the best first-day pop (+53%) for an IPO in three months, and on the same day Voyager had the best pop in almost two months (+27%). While there were no biotech filings this past week, it is a safe bet that the sector will continue find available capital in the US IPO market.
Four biotechs make up the best and worst IPOs this week
Advanced Accelerator Applications
) finished the week with a 58% gain. The company's nearly $1 billion market cap is 85% higher than its proposed value in February during the first IPO attempt. Given the terrible performance of diagnostics peer Lantheus Holdings (
; -43%), which went public in June, AAAP's investors were likely very enthusiastic about the positive results its drug candidate received in a Phase 3 trial for neuroendocrine tumors.
Backed by Third Rock,
) had shown at least one successful application of its gene therapy for advanced Parkinson's disease in a Phase 1 trial, and boasted a substantial collaboration from Genzyme. While its capital needs are intensive, the biotech went public at a $367 million market cap with $232 million in post-IPO cash.
The earliest-stage of all,
WAVE Life Biosciences
) raised $102 million by pricing at the midpoint and offering additional shares, making it the week's largest IPO. However, insiders and Teva put in for 61% of the deal. The preclinical biotech was the week's only IPO to break issue, down 1% by Friday.
) raised $60 million and began trading on the Nasdaq at $8 per ADS, well below the $12.10 its converted ADSs were listed at in Australia (and where Celgene invested in April). The regenerative stem cell biotech has several late-stage candidates and a collaboration with Teva. However, in the past 11 years it has needed to raise more capital than its current market cap, and will require more in the future.
Education software provider Instructure passes its IPO test
Two companies in the technology sector went public this week, bringing the 4Q15 up to five.
), which provides learning management software for schools and corporations, raised $70 million this week. It added enough insider buying on Monday to cover 24% of the deal in total, but by the time of pricing it had found enough investors to purchase the entire deal at $16, the low end of the proposed range. Those investors were rewarded with a 13% gain, putting it above most tech IPOs this year.
Cutting fiber optics leads to flat debut for Xtera
Much like recent IPO Adesto Technologies (
) was backed by ARCH Ventures and other notable VCs, positioned its technology as being at an inflection point and ended up delaying and pricing the IPO at $5 - half the proposed midpoint. Xtera ended the week where it priced.
) postponed its $510 million IPO at a proposed market cap of $2.5 billion. Despite its high growth and online angle, investors appeared unwilling to give the mortgage company a valuation in line with public online lenders like LendingClub (
Sole Elite Group
) will again attempt to price its IPO next week.
7 IPOs during the week of November 9, 2015
Deal size ($mm)
IPO price vs. midpoint
Return at 11/13
Advanced Accelerator Applications (
Biotech and diagnostics
Voyager Therapeutics (
Biotech: Gene therapy for Parkinson's
Equity Bancshares (
Midwest commercial bank
Biotech: Stem cells
Xtera Communications (
Fiber optic networking
WAVE Life Sciences (
Biotech: RNA therapies
Find out why institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is down 7% year-to-date, compared to -1% for the S&P 500. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Citizens Financial Group (
) and Hilton Worldwide (
). The Renaissance International IPO Index is down 3% year-to-date, compared to -5% for ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Samsung C+T.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.